|Bid||153.20 x 1100|
|Ask||153.72 x 800|
|Day's Range||148.15 - 156.56|
|52 Week Range||109.88 - 176.66|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||48.50|
|Earnings Date||Apr 22, 2020 - Apr 26, 2020|
|Forward Dividend & Yield||0.64 (0.41%)|
|Ex-Dividend Date||Apr 20, 2020|
|1y Target Est||168.75|
While the S&P; MidCap 400 fell as much as 44% from its peak, West Pharmaceutical held up much better. Will it lead other coronavirus stocks to watch?
A total of 11 of the 50 largest Philadelphia-area public companies lost more than 50% of their stock value.
Assessing West Pharmaceutical Services, Inc.'s (NYSE:WST) past track record of performance is a useful exercise for...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
West Pharmaceutical Services shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share. The dividend will be paid on May 6, 2020, to shareholders of record as of April 22, 2020.
It's been a good week for West Pharmaceutical Services (NYSE:WST) shareholders, because the company has just released...
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr. Friel, West's Board of Directors increases in size to 11 directors.
West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.89% and 4.07%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
(Booth B58) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce several new, innovative pharmaceutical containment and closure offerings at Pharmapack, February 5-6 in Paris, France. The Company expands its innovations for global customers and their patients with the introduction of two AccelTRA® component line extensions; a Flip-Off® Seal container closure system (CCS) compatible with the 5mL Daikyo Crystal Zenith® vial; and the new Ready Pack™ system with SCHOTT's adaptiQ® platform, resulting from West's recent partnership expansion with the leading packaging supplier.
The acquisition is a step forward in Quest Diagnostics' (DGX) commitment toward offering high-quality, cost-efficient diagnostic services in Texas,especially the Houston metropolitan area.